Some peptides are FDA-approved drugs. Most research peptides are not. This guide explains the difference, which compounds have approval, what the 2023 compounding guidance changed, and what 'not approved' actually means for research use.
FDA-Approved Peptides
These peptides have completed the full FDA approval process — preclinical studies, Phase I/II/III clinical trials, and NDA/BLA review. They are legally available as prescription drugs for their approved indications.
Research Peptides: Not FDA-Approved
These are the most commonly researched peptides. None have received FDA approval for human use. They are legal to purchase and use for laboratory research in the United States.
The FDA Drug Approval Process
The process takes 10–15 years and costs $1–2 billion on average — which is why many promising research compounds never reach the market despite significant preclinical evidence.